|
Post by u1682002 on Oct 14, 2016 10:59:32 GMT -5
One of message that I posted a couple of days ago got deleted without any explanation. It could be either the technical reason or other reason. Basically i was trying to find out if anyone from the board actually followed up with the following so-called confidential treatment for information.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
26 August 2011
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
MannKind Corporation
File No. 0-50865 -- CF# 27156
_____________________
MannKind Corporation submitted an application under Rule 24b-2 requesting
confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed
on August 4, 2011.
Based on representations by MannKind Corporation that this information
qualifies as confidential commercial or financial information under the Freedom of
Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined
not to publicly disclose it. Accordingly, excluded information from the following
exhibit(s) will not be released to the public for the time period(s) specified:
Exhibit 10.3 through June 24, 2016
For the Commission, by the Division of Corporation Finance, pursuant to
delegated authority:
Timothy S. Levenberg
Special Counsel
|
|
|
Post by burki on Oct 14, 2016 14:32:28 GMT -5
Try using fewer characters in the SEC search i.e only CF2715 This may give an indication of what the Exhibit 10.3 might be/is about. (Adjustments to Civil Monetary Penalty Amounts)
|
|
|
Post by solange on Oct 14, 2016 14:46:51 GMT -5
Confidential treatment Ended June 2016
|
|
|
Post by matt on Oct 14, 2016 15:00:02 GMT -5
It was not a big deal; the CTO covered a now defunct supply agreement between Mannkind and Organon Technica with a value of $16 million. Since the contract recited quantities received for that price, Organon likely did not want their pricing exposed in a public forum so confidential treatment was allowed. If you want to see the unredacted material, you can request it from the SEC.
Virtually all CTOs are matters of this type where a third party does not want to disclose pricing or other contract terms. They are pretty routine.
|
|
|
Post by rockstarrick on Oct 17, 2016 5:29:42 GMT -5
|
|